嵌合抗原受体-话题@MedSci

#嵌合抗原受体#

17篇内容 | 2009人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2248893, encodeId=7659224889306, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a> <a href='/topic/show?id=f58792059c3' target=_blank style='color:#2F92EE;'>#调节性T细胞#</a> <a href='/topic/show?id=668f123521f0' target=_blank style='color:#2F92EE;'>#CAR Treg#</a>, objectTitle=Mol Ther子刊：CAR Treg细胞的新突破为自身免疫疾病带来曙光！, objectType=article, longId=860191, objectId=fd1c86019175, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20250118/1737186601830_2185383.png, objectUrl=/article/show_article.do?id=fd1c86019175, replyNumber=0, likeNumber=0, createdTime=2025-01-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200380, encodeId=606d220038067, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a> <a href='/topic/show?id=55a39e23019' target=_blank style='color:#2F92EE;'>#间充质基质细胞#</a> <a href='/topic/show?id=b75c113e9583' target=_blank style='color:#2F92EE;'>#CAR-MSC#</a>, objectTitle=Nature子刊：新研究发现表达嵌合抗原受体的MSC细胞有望治疗一系列自身免疫性疾病, objectType=article, longId=823113, objectId=01378231131e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240424/1713970731786_2185383.png, objectUrl=/article/show_article.do?id=01378231131e, replyNumber=0, likeNumber=128, createdTime=2024-04-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195007, encodeId=4922219500efe, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a> <a href='/topic/show?id=ae37204e848' target=_blank style='color:#2F92EE;'>#不良事件#</a> <a href='/topic/show?id=37ea11264e47' target=_blank style='color:#2F92EE;'>#CAR-T 细胞疗法#</a>, objectTitle=Blood：第二原发恶性肿瘤在CAR-T细胞治疗后的不良事件中所占比例很小, objectType=article, longId=817810, objectId=094b81e810b8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240323/1711176666289_2185383.png, objectUrl=/article/show_article.do?id=094b81e810b8, replyNumber=0, likeNumber=189, createdTime=2024-03-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188687, encodeId=7149218868eae, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a> <a href='/topic/show?id=eff610e95796' target=_blank style='color:#2F92EE;'>#CAR-T 细胞#</a> <a href='/topic/show?id=c38de2137e4' target=_blank style='color:#2F92EE;'>#皮肤黑色素瘤#</a> <a href='/topic/show?id=157111140eca' target=_blank style='color:#2F92EE;'>#TYRP1#</a>, objectTitle=Nat Commun：靶向TYRP1的CAR-T细胞有望治疗皮肤黑色素瘤和罕见黑色素瘤亚型, objectType=article, longId=813685, objectId=873c813685fe, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240217/1708164868657_2185383.png, objectUrl=/article/show_article.do?id=873c813685fe, replyNumber=0, likeNumber=83, createdTime=2024-02-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2181924, encodeId=208521819243d, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a> <a href='/topic/show?id=0459282e527' target=_blank style='color:#2F92EE;'>#儿童急性淋巴细胞白血病#</a>, objectTitle=Cancer Rep：嵌合抗原受体(CAR) T细胞治疗儿童急性淋巴细胞白血病的医疗成本, objectType=article, longId=809546, objectId=2d4780954613, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696895133889_4754896.jpeg, objectUrl=/article/show_article.do?id=2d4780954613, replyNumber=0, likeNumber=92, createdTime=2024-01-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2d4780954613, moduleTitle=Cancer Rep：嵌合抗原受体(CAR) T细胞治疗儿童急性淋巴细胞白血病的医疗成本, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d4780954613)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1626748, encodeId=83591626e4858, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=博生吉靶向B7-H3嵌合抗原受体T细胞注射液获得美国FDA罕见儿科疾病（RPD）认定, objectType=article, longId=724805, objectId=f9ffe2480599, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9ffe2480599, replyNumber=0, likeNumber=124, createdTime=2022-04-24, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9ffe2480599, moduleTitle=博生吉靶向B7-H3嵌合抗原受体T细胞注射液获得美国FDA罕见儿科疾病（RPD）认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9ffe2480599)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626747, encodeId=802e1626e479d, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=J Clin Oncol：B细胞成熟抗原和CD19嵌合抗原受体T细胞联合治疗多发性骨髓瘤的长期疗效, objectType=article, longId=301786, objectId=fb92301e86b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb92301e86b3, replyNumber=0, likeNumber=82, createdTime=2022-03-29, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb92301e86b3, moduleTitle=J Clin Oncol：B细胞成熟抗原和CD19嵌合抗原受体T细胞联合治疗多发性骨髓瘤的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb92301e86b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626746, encodeId=931e1626e46d6, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=J Clin Oncol：供体来源CD7嵌合抗原受体T细胞治疗急性T淋巴细胞白血病的未来可期！, objectType=article, longId=215210, objectId=517621521090, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=517621521090, replyNumber=0, likeNumber=106, createdTime=2021-08-04, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=517621521090, moduleTitle=J Clin Oncol：供体来源CD7嵌合抗原受体T细胞治疗急性T淋巴细胞白血病的未来可期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=517621521090)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626745, encodeId=bf971626e4539, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗, objectType=article, longId=201430, objectId=394e2014304d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=394e2014304d, replyNumber=0, likeNumber=93, createdTime=2020-10-02, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=394e2014304d, moduleTitle=J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=394e2014304d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626744, encodeId=9e0b1626e4401, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=Blood：嵌合抗原受体T细胞疗法的临床效果、管理和神经毒性, objectType=article, longId=163410, objectId=3d86163410a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d86163410a2, replyNumber=0, likeNumber=115, createdTime=2019-04-03, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d86163410a2, moduleTitle=Blood：嵌合抗原受体T细胞疗法的临床效果、管理和神经毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d86163410a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626743, encodeId=822e1626e43f0, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=Lancet oncol：Axicabtagene ciloleucel（自体抗CD19嵌合抗原受体T细胞疗法）治疗复发性/难治性大B细胞淋巴瘤的长期安全性和疗, objectType=article, longId=155389, objectId=074b15538986, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=074b15538986, replyNumber=0, likeNumber=66, createdTime=2018-12-10, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=074b15538986, moduleTitle=Lancet oncol：Axicabtagene ciloleucel（自体抗CD19嵌合抗原受体T细胞疗法）治疗复发性/难治性大B细胞淋巴瘤的长期安全性和疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=074b15538986)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626742, encodeId=a4ae1626e4212, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=Neurology：继发于嵌合抗原受体T细胞免疫治疗的脑水肿, objectType=article, longId=155314, objectId=b5a0155314e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5a0155314e1, replyNumber=0, likeNumber=94, createdTime=2018-12-08, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5a0155314e1, moduleTitle=Neurology：继发于嵌合抗原受体T细胞免疫治疗的脑水肿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5a0155314e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626741, encodeId=eade1626e4180, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=Blood：将嵌合抗原受体引物T细胞不能完全解决前体B细胞ALL诱导的T细胞功能障碍, objectType=article, longId=148878, objectId=e5361488e821, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5361488e821, replyNumber=0, likeNumber=125, createdTime=2018-09-16, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5361488e821, moduleTitle=Blood：将嵌合抗原受体引物T细胞不能完全解决前体B细胞ALL诱导的T细胞功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5361488e821)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626740, encodeId=1e821626e4088, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=Blood：抗CD37嵌合抗原受体T细胞可有效治疗B/T细胞淋巴瘤, objectType=article, longId=146567, objectId=eb5714656e5e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb5714656e5e, replyNumber=0, likeNumber=128, createdTime=2018-08-15, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb5714656e5e, moduleTitle=Blood：抗CD37嵌合抗原受体T细胞可有效治疗B/T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb5714656e5e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626739, encodeId=c6ed1626e3990, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=2018 专家共识：儿童接受嵌合抗原受体T细胞治疗管理指南, objectType=article, longId=146447, objectId=f7b614644e16, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7b614644e16, replyNumber=0, likeNumber=100, createdTime=2018-08-13, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7b614644e16, moduleTitle=2018 专家共识：儿童接受嵌合抗原受体T细胞治疗管理指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7b614644e16)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626738, encodeId=adb91626e3876, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=Blood：非病毒RNA嵌合抗原受体修饰的T细胞用于霍奇金淋巴瘤患者的疗效和安全性, objectType=article, longId=141232, objectId=07e8141232cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07e8141232cc, replyNumber=0, likeNumber=104, createdTime=2018-06-23, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07e8141232cc, moduleTitle=Blood：非病毒RNA嵌合抗原受体修饰的T细胞用于霍奇金淋巴瘤患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07e8141232cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626737, encodeId=5e0c1626e37d1, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=Blood：预注射多功能的抗CD19的嵌合抗原受体T细胞可改善NHL患者的临床预后, objectType=article, longId=140802, objectId=f297140802b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f297140802b9, replyNumber=0, likeNumber=95, createdTime=2018-06-16, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f297140802b9, moduleTitle=Blood：预注射多功能的抗CD19的嵌合抗原受体T细胞可改善NHL患者的临床预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f297140802b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626736, encodeId=ffca1626e367c, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=Blood：靶向CD19的嵌合抗原受体修饰的T细胞免疫疗法的感染性并发症研究。, objectType=article, longId=116944, objectId=9e6111694445, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e6111694445, replyNumber=0, likeNumber=83, createdTime=2017-10-22, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e6111694445, moduleTitle=Blood：靶向CD19的嵌合抗原受体修饰的T细胞免疫疗法的感染性并发症研究。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e6111694445)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626735, encodeId=025c1626e35c0, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=Blood：嵌合抗原受体（CARs）为多发性骨髓瘤带来新的治疗前景。, objectType=article, longId=113425, objectId=4e18113425e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e18113425e4, replyNumber=0, likeNumber=97, createdTime=2017-09-22, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e18113425e4, moduleTitle=Blood：嵌合抗原受体（CARs）为多发性骨髓瘤带来新的治疗前景。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e18113425e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1626749, encodeId=fb9a1626e4904, content=<a href='/topic/show?id=2b104e82656' target=_blank style='color:#2F92EE;'>#嵌合抗原受体#</a>, objectTitle=嵌合抗原受体T（CAR-T）细胞免疫疗法的风险与回报, objectType=article, longId=88742, objectId=e66488e4287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e66488e4287, replyNumber=0, likeNumber=112, createdTime=2017-02-15, rootId=0, userName=dangious, userId=77a421060517, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e66488e4287, moduleTitle=嵌合抗原受体T（CAR-T）细胞免疫疗法的风险与回报, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e66488e4287)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

嵌合抗原受体

2020-05-29

梅斯管理员

前往app查看评论内容

2025-01-20发表于上海

梅斯管理员

前往app查看评论内容

2024-04-25发表于上海

梅斯管理员

前往app查看评论内容

2024-03-24发表于上海

梅斯管理员

前往app查看评论内容

2024-02-22发表于上海

梅斯管理员

#嵌合抗原受体# #儿童急性淋巴细胞白血病#

Cancer Rep：嵌合抗原受体(CAR) T细胞治疗儿童急性淋巴细胞白血病的医疗成本

2024-01-16发表于上海

dangious

#嵌合抗原受体#

博生吉靶向B7-H3嵌合抗原受体T细胞注射液获得美国FDA罕见儿科疾病（RPD）认定

2022-04-24

dangious

#嵌合抗原受体#

J Clin Oncol：B细胞成熟抗原和CD19嵌合抗原受体T细胞联合治疗多发性骨髓瘤的长期疗效

2022-03-29

dangious

#嵌合抗原受体#

J Clin Oncol：供体来源CD7嵌合抗原受体T细胞治疗急性T淋巴细胞白血病的未来可期！

2021-08-04

dangious

#嵌合抗原受体#

J Clin Oncol：优化成人急性淋巴细胞白血病患者的嵌合抗原受体T细胞治疗

2020-10-02

dangious

#嵌合抗原受体#

Blood：嵌合抗原受体T细胞疗法的临床效果、管理和神经毒性

2019-04-03

dangious

#嵌合抗原受体#

Lancet oncol：Axicabtagene ciloleucel（自体抗CD19嵌合抗原受体T细胞疗法）治疗复发性/难治性大B细胞淋巴瘤的长期安全性和疗

2018-12-10

dangious

#嵌合抗原受体#

Neurology：继发于嵌合抗原受体T细胞免疫治疗的脑水肿

2018-12-08

dangious

#嵌合抗原受体#

Blood：将嵌合抗原受体引物T细胞不能完全解决前体B细胞ALL诱导的T细胞功能障碍

2018-09-16

dangious

#嵌合抗原受体#

Blood：抗CD37嵌合抗原受体T细胞可有效治疗B/T细胞淋巴瘤

2018-08-15

dangious

#嵌合抗原受体#

2018 专家共识：儿童接受嵌合抗原受体T细胞治疗管理指南

2018-08-13

dangious

#嵌合抗原受体#

Blood：非病毒RNA嵌合抗原受体修饰的T细胞用于霍奇金淋巴瘤患者的疗效和安全性

2018-06-23

dangious

#嵌合抗原受体#

Blood：预注射多功能的抗CD19的嵌合抗原受体T细胞可改善NHL患者的临床预后

2018-06-16

dangious

#嵌合抗原受体#

Blood：靶向CD19的嵌合抗原受体修饰的T细胞免疫疗法的感染性并发症研究。

2017-10-22

dangious

#嵌合抗原受体#

Blood：嵌合抗原受体（CARs）为多发性骨髓瘤带来新的治疗前景。

2017-09-22

dangious

#嵌合抗原受体#

嵌合抗原受体T（CAR-T）细胞免疫疗法的风险与回报

2017-02-15

科室
- - 订阅+
  - 更多科室
工具
服务